March madness has nothing on Wall Street as the first Monday in the month kicks off with several multi-billion dollar deals. First up on March 1 is the merger of chipmaker Freescale Semiconductors with NXP Semiconductors in a deal the companies said had an enterprise value of $40 billion. In healthcare there were two mega-medtech deals. Boston Scientific bought Endo International’s urology device portfolio for more than $1.6 billion, while Johnson & Johnson sold its cardiac device unit to Cardinal health for more than $1.9 billion. Both deals are part of strategic divestiture programs by the sellers.
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source
